These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25674719)

  • 1. Immunotherapy for melanoma using programmed death 1 checkpoint inhibitors.
    Hamid O
    Clin Adv Hematol Oncol; 2014 Nov; 12(11):782-4. PubMed ID: 25674719
    [No Abstract]   [Full Text] [Related]  

  • 2. Programmed death protein 1 inhibitors making inroads in multiple cancers.
    Brower V
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25957444
    [No Abstract]   [Full Text] [Related]  

  • 3. PD-1 inhibitor approved for melanoma.
    Cancer Discov; 2014 Nov; 4(11):1249. PubMed ID: 25367933
    [No Abstract]   [Full Text] [Related]  

  • 4. Scleroderma Induced by Pembrolizumab: A Case Series.
    Barbosa NS; Wetter DA; Wieland CN; Shenoy NK; Markovic SN; Thanarajasingam U
    Mayo Clin Proc; 2017 Jul; 92(7):1158-1163. PubMed ID: 28599746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Inhibitors for Treatment of Metastatic Melanoma of the Orbit and Ocular Adnexa.
    Ford J; Thuro BA; Thakar S; Hwu WJ; Richani K; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2017; 33(4):e82-e85. PubMed ID: 27662198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new frontier in treatment of advanced melanoma: Redefining clinical management in the era of immune checkpoint inhibitors.
    Levine O; Devji T; Xie F
    Hum Vaccin Immunother; 2017 Aug; 13(8):1765-1767. PubMed ID: 28481695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1 Blockers.
    Wolchok JD
    Cell; 2015 Aug; 162(5):937. PubMed ID: 26317459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pembrolizumab joins the anti-PD-1 armamentarium in the treatment of melanoma.
    Hersey P; Gowrishankar K
    Future Oncol; 2015; 11(1):133-40. PubMed ID: 25572788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Association of Cancer Research Showcases Immunotherapy Advances.
    Brower V
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26243202
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the pharmacokinetics and metabolism of pembrolizumab in the treatment of melanoma.
    Longoria TC; Tewari KS
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1247-53. PubMed ID: 27485741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pembrolizumab for the treatment of melanoma.
    Kumar SS; McNeil CM
    Expert Rev Clin Pharmacol; 2015; 8(5):515-27. PubMed ID: 26146011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of pembrolizumab for the treatment of melanoma.
    Martin-Liberal J; Kordbacheh T; Larkin J
    Expert Opin Drug Saf; 2015 Jun; 14(6):957-64. PubMed ID: 25927979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locally Advanced Unresectable Vaginal Melanoma: Response With Anti-Programmed Death Receptor 1.
    Chanal J; Kramkimel N; Guegan S; Moguelet P; Fourchotte V; Avril MF
    J Low Genit Tract Dis; 2016 Jan; 20(1):e4-5. PubMed ID: 26704337
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands.
    van der Kooij MK; Joosse A; Speetjens FM; Hospers GA; Bisschop C; de Groot JW; Koornstra R; Blank CU; Kapiteijn E
    Acta Oncol; 2017 Jan; 56(1):101-103. PubMed ID: 27911126
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous Metastatic Melanoma Resembling a Halo Nevus, in the Setting of PD-1 Inhibition.
    Harvey NT; Millward M; Macgregor K; Bucat RP; Wood BA
    Am J Dermatopathol; 2016 Dec; 38(12):e159-e162. PubMed ID: 27870733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma.
    Cheah CY; Fowler NH; Neelapu SS
    Curr Opin Oncol; 2015 Sep; 27(5):384-91. PubMed ID: 26248256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pembrolizumab for the treatment of melanoma: updates and perspectives.].
    Chiarion Sileni V; Mandalà M; Queirolo P
    Recenti Prog Med; 2017 Dec; 108(12):528-531. PubMed ID: 29297903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Not Available].
    Bounaix L; Bendouda M; Bay JO; Lemal R
    Bull Cancer; 2016 Nov; 103 Suppl 1():S160-S163. PubMed ID: 28057180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapy in lung cancer: checkpoint inhibitors].
    Wehler T; Wehler B; Stehle I
    Dtsch Med Wochenschr; 2015 Dec; 140(24):1835-8. PubMed ID: 26625234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1 inhibitors effective in hodgkin lymphoma.
    Cancer Discov; 2015 Feb; 5(2):102-3. PubMed ID: 25656882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.